Cargando…
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
Shigella is a leading cause of moderate to severe diarrhea worldwide and of diarrhea-associated deaths in children under 5 years of age in low-and middle-income countries. A vaccine against shigellosis is in high demand. SF2a-TT15, a synthetic carbohydrate-based conjugate vaccine candidate against S...
Autores principales: | Meron-Sudai, Shiri, Asato, Valeria, Adler, Amos, Bialik, Anya, Goren, Sophy, Ariel-Cohen, Ortal, Reizis, Arava, Mulard, Laurence A., Phalipon, Armelle, Cohen, Dani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998260/ https://www.ncbi.nlm.nih.gov/pubmed/36894570 http://dx.doi.org/10.1038/s41541-023-00624-y |
Ejemplares similares
-
Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022) -
Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate
por: Toapanta, Franklin R., et al.
Publicado: (2023) -
Detoxified O-Specific Polysaccharide (O-SP)–Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene
por: Cohen, Dani, et al.
Publicado: (2022) -
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023) -
Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study
por: Chisenga, Caroline C., et al.
Publicado: (2021)